Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000180429 | SCV000232862 | benign | not specified | 2015-02-27 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000756261 | SCV000884015 | likely benign | not provided | 2017-12-28 | criteria provided, single submitter | clinical testing | The HSPG2 p.Arg3906Gln variant (rs78944354) has not been reported in association with disease and is classified as benign in ClinVar (Variant ID: 198963). The p.Arg3906Gln variant is also listed in the Genome Aggregation Database (gnomAD) browser with an allele frequency of 0.55% in the African population (identified in 119 out of 21,738 chromosomes with 1 homozygote). The arginine at codon 3906 is weakly conserved considering 12 species (Alamut software v2.10.0), and multiple species have a glutamine at this position, which suggests that this change is tolerated by evolution. Although computational analyses predict conflicting effects of this variant on protein structure/function (SIFT: tolerated, PolyPhen2: benign, MutationTaster: disease causing), based on the available evidence, the p.Arg3906Gln variant is classified as likely benign. |
Invitae | RCV000756261 | SCV001026878 | benign | not provided | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000756261 | SCV001477273 | likely benign | not provided | 2020-04-09 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000756261 | SCV001794858 | likely benign | not provided | 2019-08-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002516819 | SCV003677111 | likely benign | Inborn genetic diseases | 2022-04-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003937638 | SCV004753656 | likely benign | HSPG2-related condition | 2019-11-12 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |